ROSE COSLETT: Open Payments
NPI 1659813160 · BOONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 35 payments from 15 companies in 2025. Trend: 2023 $108 · 2024 $95 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $195 |
| PFIZER INC. | 3 | $50 |
| Medtronic, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Alkermes, Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
| Amgen Inc. | 1 | $20 |
Products named: VRAYLAR, UBRELVY, MINIMED 780G, QULIPTA, PREVNAR 20, TRINTELLIX, CAPLYTA, REXULTI.
Industry payments across IN — which companies pay providers there.
